These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35162696)

  • 21. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
    Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
    JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report.
    Bollaerts K; Wyndham-Thomas C; Miller E; Izurieta HS; Black S; Andrews N; Rubbrecht M; Van Heuverswyn F; Neels P
    Biologicals; 2024 Feb; 85():101750. PubMed ID: 38360428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When Can We Trust Real-World Data To Evaluate New Medical Treatments?
    Simon GE; Bindman AB; Dreyer NA; Platt R; Watanabe JH; Horberg M; Hernandez A; Califf RM
    Clin Pharmacol Ther; 2022 Jan; 111(1):24-29. PubMed ID: 33932030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward.
    Akehurst R; Murphy LA; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):11-19. PubMed ID: 36706952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empowering quality data - the Gordian knot of bringing real innovation into healthcare system.
    Horgan D; Hamdi Y; Lal JA; Nyawira T; Meyer S; Kondji D; Francisco NM; De Guzman R; Paul A; Nallamalla KR; Park WY; Triapthi V; Tripathi R; Johns A; Singh MP; Phipps ME; Dube F; Abu Rasheed HM; Kozaric M; Pinto JA; Stefani SD; Aponte Rueda ME; Alarcon RF; Barrera-Saldana HA
    Diagnosis (Berl); 2023 May; 10(2):140-157. PubMed ID: 36548810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making.
    Németh B; Kamusheva M; Mitkova Z; Petykó ZI; Zemplényi A; Dimitrova M; Tachkov K; Balkányi L; Czech M; Dawoud D; Goettsch W; Hren R; Knies S; Lorenzovici L; Maravic Z; Piniazhko O; Zerovnik S; Kaló Z
    J Comp Eff Res; 2023 Apr; 12(4):e220157. PubMed ID: 36861458
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to Deal with the Inevitable: Generating Real-World Data and Using Real-World Evidence for HTA Purposes - From Theory to Action.
    Oortwijn W; Sampietro-Colom L; Trowman R
    Int J Technol Assess Health Care; 2019; 35(4):346-350. PubMed ID: 31198129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platform.
    Bourla AB; Meropol NJ
    Digit Health; 2021; 7():20552076211059975. PubMed ID: 34868623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
    Sievers H; Joos A; Hiligsmann M
    Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
    Webster J; Smith BD
    Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Evidence: A Primer.
    Dang A
    Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of real-world evidence for oncology clinical decision making in emerging economies.
    Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M
    Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors' perspective.
    Wills A; Mitha A; Cheung WY
    J Pharm Pharm Sci; 2023; 26():11877. PubMed ID: 37901362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.
    Chan K; Nam S; Evans B; de Oliveira C; Chambers A; Gavura S; Hoch J; Mercer RE; Dai WF; Beca J; Tadrous M; Isaranuwatchai W
    BMJ Open; 2020 Jan; 10(1):e032884. PubMed ID: 31915169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How can real-world evidence aid decision making during the life cycle of nonprescription medicines?
    Csoke E; Landes S; Francis MJ; Ma L; Teotico Pohlhaus D; Anquez-Traxler C
    Clin Transl Sci; 2022 Jan; 15(1):43-54. PubMed ID: 34405554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world evidence and product development: Opportunities, challenges and risk mitigation.
    Naidoo P; Bouharati C; Rambiritch V; Jose N; Karamchand S; Chilton R; Leisegang R
    Wien Klin Wochenschr; 2021 Aug; 133(15-16):840-846. PubMed ID: 33837463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus.
    Klimek P; Baltic D; Brunner M; Degelsegger-Marquez A; Garhöfer G; Gouya-Lechner G; Herzog A; Jilma B; Kähler S; Mikl V; Mraz B; Ostermann H; Röhl C; Scharinger R; Stamm T; Strassnig M; Wirthumer-Hoche C; Pleiner-Duxneuner J
    JMIR Med Inform; 2022 Jun; 10(6):e34204. PubMed ID: 35713954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.